Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lyme Disease | 47 | 2024 | 631 | 12.030 |
Why?
|
Meningitis, Bacterial | 35 | 2024 | 221 | 7.330 |
Why?
|
Head Injuries, Closed | 7 | 2019 | 133 | 3.070 |
Why?
|
Spinal Puncture | 15 | 2020 | 282 | 2.690 |
Why?
|
Serologic Tests | 9 | 2024 | 381 | 2.580 |
Why?
|
Emergency Service, Hospital | 59 | 2024 | 7879 | 2.430 |
Why?
|
Diabetic Ketoacidosis | 13 | 2023 | 253 | 2.430 |
Why?
|
Fever | 22 | 2024 | 1618 | 2.370 |
Why?
|
Immunoenzyme Techniques | 7 | 2021 | 1705 | 2.220 |
Why?
|
Bacterial Infections | 11 | 2024 | 1390 | 2.110 |
Why?
|
Meningitis, Aseptic | 9 | 2013 | 59 | 2.070 |
Why?
|
Cerebrospinal Fluid Shunts | 5 | 2018 | 195 | 1.920 |
Why?
|
Bacteremia | 14 | 2024 | 979 | 1.740 |
Why?
|
Meningitis | 7 | 2023 | 217 | 1.630 |
Why?
|
Decision Support Techniques | 13 | 2019 | 1998 | 1.540 |
Why?
|
Meningitis, Viral | 6 | 2017 | 50 | 1.540 |
Why?
|
Cerebrospinal Fluid | 14 | 2021 | 544 | 1.440 |
Why?
|
Arthritis, Infectious | 7 | 2024 | 347 | 1.400 |
Why?
|
Borrelia burgdorferi | 8 | 2024 | 183 | 1.390 |
Why?
|
Lyme Neuroborreliosis | 5 | 2020 | 50 | 1.390 |
Why?
|
Child | 119 | 2024 | 80153 | 1.360 |
Why?
|
Wounds, Nonpenetrating | 7 | 2015 | 807 | 1.290 |
Why?
|
Infant | 93 | 2024 | 36192 | 1.270 |
Why?
|
Endemic Diseases | 6 | 2024 | 190 | 1.260 |
Why?
|
Leukocyte Count | 14 | 2024 | 1596 | 1.240 |
Why?
|
Polymerase Chain Reaction | 11 | 2019 | 6075 | 1.200 |
Why?
|
Facial Paralysis | 4 | 2017 | 346 | 1.160 |
Why?
|
Skull Fractures | 4 | 2020 | 202 | 1.140 |
Why?
|
Synovial Fluid | 4 | 2024 | 393 | 1.140 |
Why?
|
Leukocytosis | 10 | 2021 | 251 | 1.140 |
Why?
|
Fluid Therapy | 9 | 2023 | 579 | 1.120 |
Why?
|
Immunoblotting | 3 | 2019 | 1646 | 1.080 |
Why?
|
Sensitivity and Specificity | 33 | 2024 | 14666 | 1.060 |
Why?
|
Erythema Chronicum Migrans | 2 | 2023 | 48 | 1.060 |
Why?
|
Enterovirus | 4 | 2017 | 67 | 1.000 |
Why?
|
Child, Preschool | 63 | 2024 | 42230 | 0.980 |
Why?
|
Enterovirus Infections | 5 | 2017 | 74 | 0.970 |
Why?
|
Anti-Bacterial Agents | 19 | 2024 | 7407 | 0.950 |
Why?
|
Brain Injuries | 7 | 2022 | 2053 | 0.950 |
Why?
|
Ceftriaxone | 4 | 2023 | 175 | 0.920 |
Why?
|
Antibodies, Bacterial | 8 | 2024 | 1469 | 0.910 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.870 |
Why?
|
Craniocerebral Trauma | 6 | 2020 | 490 | 0.860 |
Why?
|
Immunoglobulin M | 6 | 2024 | 1527 | 0.830 |
Why?
|
Tomography, X-Ray Computed | 18 | 2020 | 20570 | 0.830 |
Why?
|
Cerebrospinal Fluid Proteins | 5 | 2018 | 72 | 0.810 |
Why?
|
Adolescent | 72 | 2024 | 88319 | 0.780 |
Why?
|
Ondansetron | 2 | 2020 | 95 | 0.770 |
Why?
|
Bicycling | 2 | 2014 | 177 | 0.760 |
Why?
|
Accidents, Traffic | 4 | 2015 | 816 | 0.730 |
Why?
|
Ixodes | 1 | 2020 | 40 | 0.720 |
Why?
|
Antiemetics | 2 | 2020 | 186 | 0.710 |
Why?
|
Doxycycline | 2 | 2023 | 344 | 0.710 |
Why?
|
Herpes Simplex | 6 | 2022 | 478 | 0.700 |
Why?
|
Clinical Enzyme Tests | 1 | 2019 | 113 | 0.680 |
Why?
|
Retrospective Studies | 78 | 2024 | 80636 | 0.670 |
Why?
|
Complement C6 | 1 | 2018 | 14 | 0.650 |
Why?
|
Pediatrics | 10 | 2024 | 3589 | 0.650 |
Why?
|
Infant, Newborn | 47 | 2022 | 26198 | 0.650 |
Why?
|
Otitis Media | 2 | 2020 | 286 | 0.650 |
Why?
|
Skull | 2 | 2015 | 818 | 0.630 |
Why?
|
Humans | 192 | 2024 | 761504 | 0.630 |
Why?
|
Diagnosis, Differential | 19 | 2022 | 12974 | 0.610 |
Why?
|
Herpes Zoster Oticus | 1 | 2017 | 7 | 0.600 |
Why?
|
Hospitals, Pediatric | 11 | 2019 | 1860 | 0.590 |
Why?
|
Glasgow Coma Scale | 7 | 2021 | 580 | 0.590 |
Why?
|
Hospitalization | 14 | 2021 | 10723 | 0.590 |
Why?
|
Urinary Tract Infections | 7 | 2022 | 802 | 0.590 |
Why?
|
Emergency Medicine | 4 | 2021 | 1198 | 0.580 |
Why?
|
Multi-Institutional Systems | 1 | 2017 | 43 | 0.570 |
Why?
|
Facial Nerve Injuries | 1 | 2017 | 64 | 0.570 |
Why?
|
Cross-Sectional Studies | 37 | 2023 | 26125 | 0.560 |
Why?
|
Male | 112 | 2024 | 360804 | 0.550 |
Why?
|
C-Reactive Protein | 3 | 2019 | 3826 | 0.550 |
Why?
|
Bibliometrics | 1 | 2020 | 352 | 0.540 |
Why?
|
Female | 114 | 2024 | 392644 | 0.530 |
Why?
|
Publishing | 2 | 2020 | 833 | 0.530 |
Why?
|
Simplexvirus | 4 | 2022 | 803 | 0.510 |
Why?
|
Knee Joint | 3 | 2022 | 1676 | 0.500 |
Why?
|
Bacteria | 6 | 2022 | 2199 | 0.490 |
Why?
|
Accidental Falls | 2 | 2014 | 1068 | 0.480 |
Why?
|
Emergency Treatment | 4 | 2021 | 496 | 0.480 |
Why?
|
Prospective Studies | 27 | 2023 | 54425 | 0.470 |
Why?
|
Hydrocephalus | 3 | 2018 | 764 | 0.470 |
Why?
|
Rheumatology | 5 | 2021 | 615 | 0.470 |
Why?
|
Nursing Diagnosis | 1 | 2013 | 16 | 0.450 |
Why?
|
Physician-Nurse Relations | 1 | 2013 | 20 | 0.450 |
Why?
|
Periodicals as Topic | 3 | 2024 | 1463 | 0.420 |
Why?
|
Advisory Committees | 1 | 2017 | 787 | 0.420 |
Why?
|
Mental Recall | 1 | 2019 | 1214 | 0.410 |
Why?
|
Quality Improvement | 3 | 2017 | 3801 | 0.400 |
Why?
|
Clinical Medicine | 1 | 2013 | 145 | 0.400 |
Why?
|
Cervical Vertebrae | 4 | 2013 | 980 | 0.390 |
Why?
|
Trauma Severity Indices | 5 | 2015 | 478 | 0.390 |
Why?
|
Spinal Injuries | 2 | 2012 | 301 | 0.390 |
Why?
|
Informed Consent | 1 | 2018 | 1008 | 0.380 |
Why?
|
Hip Joint | 1 | 2018 | 1014 | 0.380 |
Why?
|
Neutrophils | 5 | 2024 | 3767 | 0.370 |
Why?
|
Cohort Studies | 25 | 2023 | 41487 | 0.350 |
Why?
|
Arthropod Vectors | 1 | 2008 | 6 | 0.320 |
Why?
|
Research | 1 | 2017 | 1982 | 0.310 |
Why?
|
Emergencies | 3 | 2021 | 1217 | 0.310 |
Why?
|
Tularemia | 1 | 2008 | 42 | 0.310 |
Why?
|
Glucose | 5 | 2023 | 4346 | 0.310 |
Why?
|
Blood Cell Count | 4 | 2019 | 397 | 0.310 |
Why?
|
Tick-Borne Diseases | 1 | 2008 | 36 | 0.310 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3810 | 0.310 |
Why?
|
Parents | 3 | 2019 | 3563 | 0.310 |
Why?
|
Blood Sedimentation | 2 | 2019 | 235 | 0.310 |
Why?
|
Francisella tularensis | 1 | 2008 | 62 | 0.300 |
Why?
|
Child Abuse | 1 | 2017 | 1077 | 0.300 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 746 | 0.300 |
Why?
|
Emergency Medical Services | 4 | 2021 | 1923 | 0.290 |
Why?
|
Pneumococcal Vaccines | 2 | 2008 | 397 | 0.290 |
Why?
|
False Negative Reactions | 2 | 2020 | 573 | 0.280 |
Why?
|
Predictive Value of Tests | 14 | 2021 | 15266 | 0.280 |
Why?
|
Lyme Disease Vaccines | 1 | 2006 | 18 | 0.280 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 401 | 0.270 |
Why?
|
Insulin | 1 | 2021 | 6596 | 0.270 |
Why?
|
Heart Ventricles | 1 | 2018 | 3807 | 0.270 |
Why?
|
Status Epilepticus | 3 | 2017 | 460 | 0.260 |
Why?
|
Boston | 8 | 2019 | 9326 | 0.260 |
Why?
|
Vomiting | 2 | 2020 | 651 | 0.260 |
Why?
|
Immunoglobulin G | 4 | 2024 | 4544 | 0.260 |
Why?
|
Erythrocytes | 3 | 2017 | 2413 | 0.260 |
Why?
|
Central Nervous System Viral Diseases | 2 | 2018 | 40 | 0.260 |
Why?
|
Thrombocytosis | 1 | 2006 | 89 | 0.260 |
Why?
|
Guideline Adherence | 2 | 2015 | 2220 | 0.260 |
Why?
|
United States | 31 | 2024 | 72334 | 0.250 |
Why?
|
Skin Pigmentation | 1 | 2007 | 277 | 0.250 |
Why?
|
Clinical Competence | 2 | 2018 | 4792 | 0.250 |
Why?
|
Young Adult | 21 | 2024 | 59243 | 0.240 |
Why?
|
Equipment Failure | 2 | 2018 | 578 | 0.240 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5840 | 0.230 |
Why?
|
Neurology | 3 | 2021 | 780 | 0.230 |
Why?
|
Health Services Research | 3 | 2021 | 1812 | 0.230 |
Why?
|
Risk Factors | 23 | 2024 | 74206 | 0.230 |
Why?
|
Labor, Obstetric | 1 | 2007 | 323 | 0.230 |
Why?
|
False Positive Reactions | 2 | 2016 | 957 | 0.220 |
Why?
|
Length of Stay | 6 | 2019 | 6425 | 0.220 |
Why?
|
Pneumococcal Infections | 1 | 2008 | 501 | 0.220 |
Why?
|
Severity of Illness Index | 7 | 2020 | 15842 | 0.220 |
Why?
|
Myocarditis | 2 | 2021 | 788 | 0.220 |
Why?
|
Family | 2 | 2019 | 3194 | 0.210 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 3415 | 0.210 |
Why?
|
Urinalysis | 6 | 2022 | 368 | 0.210 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2024 | 239 | 0.210 |
Why?
|
Pyuria | 1 | 2022 | 30 | 0.210 |
Why?
|
Pyomyositis | 1 | 2022 | 10 | 0.210 |
Why?
|
Communicable Diseases | 2 | 2021 | 875 | 0.200 |
Why?
|
Infusions, Intravenous | 3 | 2023 | 2219 | 0.200 |
Why?
|
Reproducibility of Results | 12 | 2020 | 20098 | 0.200 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2006 | 369 | 0.200 |
Why?
|
Erythrocyte Count | 2 | 2020 | 157 | 0.200 |
Why?
|
ROC Curve | 6 | 2024 | 3579 | 0.190 |
Why?
|
Pneumonia | 2 | 2023 | 2143 | 0.190 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2006 | 536 | 0.190 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7390 | 0.190 |
Why?
|
Radiography | 1 | 2012 | 6965 | 0.180 |
Why?
|
Oxadiazoles | 1 | 2001 | 94 | 0.180 |
Why?
|
Rotavirus Infections | 1 | 2002 | 84 | 0.180 |
Why?
|
Rotavirus | 1 | 2002 | 109 | 0.180 |
Why?
|
Delivery, Obstetric | 1 | 2007 | 940 | 0.180 |
Why?
|
Societies, Medical | 3 | 2020 | 3905 | 0.170 |
Why?
|
Brain Concussion | 3 | 2017 | 1404 | 0.170 |
Why?
|
Risk Assessment | 9 | 2021 | 23995 | 0.170 |
Why?
|
Lymphadenitis | 1 | 2020 | 99 | 0.170 |
Why?
|
Cerebellar Diseases | 1 | 2002 | 220 | 0.170 |
Why?
|
Biomedical Research | 3 | 2020 | 3429 | 0.170 |
Why?
|
Congresses as Topic | 2 | 2024 | 803 | 0.170 |
Why?
|
Brain Edema | 2 | 2021 | 604 | 0.160 |
Why?
|
Acidosis | 1 | 2021 | 268 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2022 | 1924 | 0.160 |
Why?
|
Algorithms | 6 | 2024 | 14031 | 0.160 |
Why?
|
Sodium | 2 | 2021 | 1588 | 0.160 |
Why?
|
Delphi Technique | 2 | 2020 | 846 | 0.160 |
Why?
|
Blood Glucose | 2 | 2023 | 6391 | 0.160 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2007 | 1033 | 0.160 |
Why?
|
Borrelia | 1 | 2019 | 66 | 0.160 |
Why?
|
Bacteriuria | 1 | 2019 | 102 | 0.160 |
Why?
|
Medical Errors | 1 | 2007 | 1263 | 0.160 |
Why?
|
Rehydration Solutions | 1 | 2018 | 43 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2022 | 407 | 0.150 |
Why?
|
Follow-Up Studies | 11 | 2018 | 39106 | 0.150 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2019 | 110 | 0.150 |
Why?
|
Pakistan | 1 | 2018 | 292 | 0.150 |
Why?
|
Ticks | 2 | 2008 | 70 | 0.140 |
Why?
|
Judgment | 1 | 2019 | 273 | 0.140 |
Why?
|
Scalp | 1 | 2020 | 389 | 0.140 |
Why?
|
Decision Support Systems, Clinical | 2 | 2019 | 1175 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2015 | 2358 | 0.140 |
Why?
|
Multivariate Analysis | 8 | 2012 | 12059 | 0.140 |
Why?
|
Financing, Organized | 1 | 2019 | 204 | 0.140 |
Why?
|
Encephalitis, Viral | 1 | 2017 | 58 | 0.140 |
Why?
|
Incidence | 9 | 2018 | 21353 | 0.140 |
Why?
|
Peer Review | 1 | 2019 | 217 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 2 | 2016 | 787 | 0.140 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2373 | 0.140 |
Why?
|
Age Factors | 9 | 2021 | 18395 | 0.140 |
Why?
|
Hypoglycemia | 2 | 2021 | 883 | 0.140 |
Why?
|
Antiviral Agents | 2 | 2017 | 3060 | 0.140 |
Why?
|
Seizures | 3 | 2021 | 2957 | 0.140 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3688 | 0.130 |
Why?
|
Prevalence | 4 | 2022 | 15732 | 0.130 |
Why?
|
Authorship | 1 | 2019 | 284 | 0.130 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 598 | 0.130 |
Why?
|
International Cooperation | 2 | 2021 | 1422 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 588 | 0.130 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 238 | 0.130 |
Why?
|
Trauma Centers | 2 | 2011 | 937 | 0.130 |
Why?
|
Hematoma | 1 | 2020 | 768 | 0.130 |
Why?
|
Seat Belts | 1 | 2015 | 60 | 0.130 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2015 | 67 | 0.130 |
Why?
|
Environment | 1 | 2021 | 1123 | 0.120 |
Why?
|
International Classification of Diseases | 3 | 2015 | 909 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 4 | 2015 | 36426 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 783 | 0.120 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 343 | 0.120 |
Why?
|
Interinstitutional Relations | 1 | 2016 | 236 | 0.120 |
Why?
|
Editorial Policies | 1 | 2019 | 458 | 0.120 |
Why?
|
Nurse Practitioners | 2 | 2018 | 271 | 0.120 |
Why?
|
Time Factors | 9 | 2020 | 39967 | 0.120 |
Why?
|
Abscess | 1 | 2018 | 606 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2019 | 703 | 0.110 |
Why?
|
Education, Nursing, Diploma Programs | 1 | 2013 | 11 | 0.110 |
Why?
|
Cell Count | 1 | 2018 | 1835 | 0.110 |
Why?
|
Confidence Intervals | 4 | 2012 | 2927 | 0.110 |
Why?
|
Ambulatory Care | 2 | 2015 | 2775 | 0.110 |
Why?
|
Physical Examination | 1 | 2020 | 1255 | 0.110 |
Why?
|
Acute Disease | 3 | 2019 | 7237 | 0.110 |
Why?
|
Head | 1 | 2019 | 924 | 0.110 |
Why?
|
Databases, Factual | 5 | 2019 | 7967 | 0.110 |
Why?
|
Comparative Effectiveness Research | 1 | 2018 | 709 | 0.100 |
Why?
|
Child Restraint Systems | 1 | 2012 | 20 | 0.100 |
Why?
|
Ataxia | 1 | 2014 | 306 | 0.100 |
Why?
|
Parenting | 1 | 2018 | 701 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2022 | 22176 | 0.100 |
Why?
|
Blood Proteins | 1 | 2017 | 1173 | 0.100 |
Why?
|
Drainage | 1 | 2018 | 1157 | 0.100 |
Why?
|
Cognition | 3 | 2023 | 6990 | 0.100 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 162 | 0.100 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 822 | 0.100 |
Why?
|
Hospital Costs | 2 | 2013 | 947 | 0.100 |
Why?
|
Diarrhea | 1 | 2018 | 1318 | 0.100 |
Why?
|
Italy | 1 | 2014 | 842 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 8654 | 0.100 |
Why?
|
Poisson Distribution | 1 | 2013 | 504 | 0.100 |
Why?
|
Absenteeism | 1 | 2013 | 247 | 0.100 |
Why?
|
Gentian Violet | 2 | 2019 | 26 | 0.100 |
Why?
|
Hypertension | 2 | 2023 | 8540 | 0.100 |
Why?
|
Statistics, Nonparametric | 3 | 2016 | 2850 | 0.100 |
Why?
|
Disease Outbreaks | 1 | 2001 | 1749 | 0.090 |
Why?
|
Phenazines | 2 | 2019 | 56 | 0.090 |
Why?
|
Cranial Nerve Diseases | 1 | 2011 | 113 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2202 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1972 | 0.090 |
Why?
|
Caustics | 1 | 2001 | 32 | 0.090 |
Why?
|
Program Evaluation | 2 | 2017 | 2495 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1265 | 0.090 |
Why?
|
Health Education | 1 | 2017 | 1052 | 0.090 |
Why?
|
Hair Preparations | 1 | 2001 | 32 | 0.090 |
Why?
|
Brain | 2 | 2014 | 27112 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1444 | 0.090 |
Why?
|
Post-Concussion Syndrome | 1 | 2013 | 243 | 0.090 |
Why?
|
Time | 1 | 2012 | 546 | 0.090 |
Why?
|
Schools | 2 | 2023 | 1489 | 0.090 |
Why?
|
Cost-Benefit Analysis | 2 | 2019 | 5492 | 0.090 |
Why?
|
Neurosurgical Procedures | 2 | 2019 | 2072 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4021 | 0.090 |
Why?
|
Esophageal Diseases | 1 | 2001 | 168 | 0.090 |
Why?
|
Pharyngeal Diseases | 1 | 2001 | 134 | 0.080 |
Why?
|
Patient Discharge | 3 | 2021 | 3443 | 0.080 |
Why?
|
Erythema | 1 | 2001 | 262 | 0.080 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 273 | 0.080 |
Why?
|
Brazil | 1 | 2013 | 1230 | 0.080 |
Why?
|
Electronic Health Records | 4 | 2024 | 4811 | 0.080 |
Why?
|
Whooping Cough | 1 | 2010 | 86 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2013 | 491 | 0.080 |
Why?
|
Logistic Models | 6 | 2019 | 13255 | 0.080 |
Why?
|
Patient Care | 1 | 2014 | 622 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2019 | 4330 | 0.080 |
Why?
|
Haemophilus influenzae type b | 1 | 2008 | 16 | 0.080 |
Why?
|
Linear Models | 3 | 2017 | 5871 | 0.080 |
Why?
|
Diptera | 1 | 2008 | 50 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1880 | 0.080 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 549 | 0.080 |
Why?
|
Meningitis, Meningococcal | 1 | 2008 | 43 | 0.080 |
Why?
|
Rest | 1 | 2013 | 918 | 0.080 |
Why?
|
Disease Reservoirs | 1 | 2008 | 121 | 0.080 |
Why?
|
Haemophilus Infections | 1 | 2008 | 94 | 0.080 |
Why?
|
Neisseria meningitidis | 1 | 2008 | 108 | 0.070 |
Why?
|
Treatment Failure | 1 | 2014 | 2645 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2169 | 0.070 |
Why?
|
Bioterrorism | 1 | 2008 | 144 | 0.070 |
Why?
|
Laryngeal Diseases | 1 | 2001 | 243 | 0.070 |
Why?
|
Radiation Injuries | 1 | 2015 | 1189 | 0.070 |
Why?
|
Sodium Chloride | 2 | 2021 | 587 | 0.070 |
Why?
|
Hyperbilirubinemia | 1 | 2007 | 74 | 0.070 |
Why?
|
Immunoassay | 2 | 2024 | 745 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 2017 | 2491 | 0.070 |
Why?
|
Zoonoses | 1 | 2008 | 179 | 0.070 |
Why?
|
Massachusetts | 5 | 2015 | 8830 | 0.070 |
Why?
|
Decision Making | 3 | 2014 | 3929 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2606 | 0.070 |
Why?
|
North America | 2 | 2021 | 1276 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 2151 | 0.070 |
Why?
|
Adult | 12 | 2024 | 221177 | 0.070 |
Why?
|
Rodentia | 1 | 2008 | 262 | 0.070 |
Why?
|
Cough | 1 | 2001 | 594 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2508 | 0.070 |
Why?
|
Health Resources | 1 | 2013 | 935 | 0.070 |
Why?
|
Radiation Dosage | 1 | 2015 | 1958 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8002 | 0.070 |
Why?
|
Odds Ratio | 5 | 2021 | 9646 | 0.070 |
Why?
|
Respiratory Sounds | 1 | 2001 | 702 | 0.070 |
Why?
|
Borrelia burgdorferi Group | 1 | 2006 | 97 | 0.070 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 6403 | 0.070 |
Why?
|
RNA | 1 | 2016 | 2726 | 0.070 |
Why?
|
Injury Severity Score | 3 | 2017 | 1045 | 0.070 |
Why?
|
Anaphylaxis | 1 | 2013 | 757 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1725 | 0.070 |
Why?
|
Consensus | 3 | 2020 | 3123 | 0.060 |
Why?
|
Spinal Cord Injuries | 1 | 2013 | 925 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 64680 | 0.060 |
Why?
|
Leukocytes | 1 | 2014 | 2026 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2651 | 0.060 |
Why?
|
Latex Fixation Tests | 1 | 2004 | 29 | 0.060 |
Why?
|
Mid-Atlantic Region | 1 | 2024 | 24 | 0.060 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2011 | 1017 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8481 | 0.060 |
Why?
|
Prognosis | 6 | 2020 | 29625 | 0.060 |
Why?
|
Intubation, Intratracheal | 1 | 2012 | 1329 | 0.060 |
Why?
|
Maryland | 1 | 2024 | 277 | 0.060 |
Why?
|
Arthritis, Psoriatic | 1 | 2006 | 219 | 0.060 |
Why?
|
Primary Health Care | 2 | 2017 | 4686 | 0.060 |
Why?
|
Headache | 1 | 2011 | 1256 | 0.060 |
Why?
|
Mass Media | 1 | 2006 | 303 | 0.050 |
Why?
|
Platelet Count | 1 | 2006 | 781 | 0.050 |
Why?
|
Medical Records | 2 | 2019 | 1408 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4016 | 0.050 |
Why?
|
Canada | 2 | 2020 | 2122 | 0.050 |
Why?
|
Survival Analysis | 2 | 2012 | 10090 | 0.050 |
Why?
|
Athletic Injuries | 1 | 2013 | 1216 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2006 | 992 | 0.050 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1527 | 0.050 |
Why?
|
Streptococcus pneumoniae | 1 | 2008 | 730 | 0.050 |
Why?
|
Public Opinion | 1 | 2006 | 484 | 0.050 |
Why?
|
Blood Urea Nitrogen | 1 | 2022 | 186 | 0.050 |
Why?
|
Seasons | 1 | 2008 | 1520 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9318 | 0.050 |
Why?
|
Internship and Residency | 2 | 2020 | 5880 | 0.050 |
Why?
|
Dehydration | 1 | 2023 | 216 | 0.050 |
Why?
|
Virginia | 1 | 2021 | 116 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1666 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13367 | 0.050 |
Why?
|
Insect Repellents | 1 | 2020 | 17 | 0.050 |
Why?
|
Romania | 1 | 2001 | 92 | 0.050 |
Why?
|
Scotland | 1 | 2001 | 143 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4853 | 0.050 |
Why?
|
Sepsis | 1 | 2014 | 2585 | 0.040 |
Why?
|
Animals | 5 | 2021 | 168459 | 0.040 |
Why?
|
Electrolytes | 1 | 2021 | 274 | 0.040 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 49 | 0.040 |
Why?
|
Drug Industry | 1 | 2006 | 788 | 0.040 |
Why?
|
Area Under Curve | 2 | 2017 | 1638 | 0.040 |
Why?
|
Communicable Diseases, Emerging | 1 | 2021 | 148 | 0.040 |
Why?
|
Oxazoles | 1 | 2001 | 199 | 0.040 |
Why?
|
Atrioventricular Block | 1 | 2021 | 133 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2020 | 503 | 0.040 |
Why?
|
Spain | 1 | 2020 | 487 | 0.040 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1117 | 0.040 |
Why?
|
Chlorides | 1 | 2021 | 665 | 0.040 |
Why?
|
Body Temperature | 1 | 2021 | 781 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 554 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2019 | 397 | 0.040 |
Why?
|
Middle Aged | 5 | 2024 | 220895 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3882 | 0.040 |
Why?
|
Registries | 2 | 2011 | 8224 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1379 | 0.040 |
Why?
|
Age Distribution | 2 | 2013 | 2880 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 503 | 0.030 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2020 | 866 | 0.030 |
Why?
|
Population Surveillance | 1 | 2007 | 2598 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2024 | 2330 | 0.030 |
Why?
|
Escherichia coli | 1 | 2008 | 4217 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 2021 | 1155 | 0.030 |
Why?
|
Hospitals, University | 1 | 2017 | 563 | 0.030 |
Why?
|
Cost Savings | 1 | 2000 | 913 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2023 | 1203 | 0.030 |
Why?
|
Trust | 1 | 2019 | 530 | 0.030 |
Why?
|
Drug Utilization | 1 | 2020 | 1188 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2176 | 0.030 |
Why?
|
Health Literacy | 1 | 2019 | 444 | 0.030 |
Why?
|
Vaccination | 1 | 2006 | 3384 | 0.030 |
Why?
|
Law Enforcement | 1 | 2015 | 112 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3322 | 0.030 |
Why?
|
Proteins | 1 | 2008 | 6032 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1181 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 749 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2013 | 2707 | 0.030 |
Why?
|
RNA, Viral | 1 | 2002 | 2846 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 437 | 0.030 |
Why?
|
Ultrasonography | 1 | 2006 | 5972 | 0.030 |
Why?
|
Anxiety | 1 | 2007 | 4573 | 0.030 |
Why?
|
Overweight | 1 | 2023 | 2417 | 0.030 |
Why?
|
Cost Control | 1 | 2015 | 628 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3205 | 0.030 |
Why?
|
Mental Disorders | 1 | 2012 | 6845 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2017 | 1186 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1376 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1913 | 0.020 |
Why?
|
Infant, Premature | 1 | 2021 | 2107 | 0.020 |
Why?
|
Program Development | 1 | 2017 | 1297 | 0.020 |
Why?
|
Accidents, Home | 1 | 2001 | 71 | 0.020 |
Why?
|
Health Care Costs | 2 | 2015 | 3242 | 0.020 |
Why?
|
Educational Measurement | 1 | 2018 | 1254 | 0.020 |
Why?
|
Memory | 1 | 2020 | 2188 | 0.020 |
Why?
|
Mentors | 1 | 2016 | 661 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4920 | 0.020 |
Why?
|
Product Labeling | 1 | 2001 | 76 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 58976 | 0.020 |
Why?
|
Genetic Markers | 1 | 2016 | 2601 | 0.020 |
Why?
|
Aged | 3 | 2024 | 169289 | 0.020 |
Why?
|
Accidents | 1 | 2010 | 165 | 0.020 |
Why?
|
Health Promotion | 1 | 2021 | 2214 | 0.020 |
Why?
|
Physicians | 2 | 2018 | 4591 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2281 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2001 | 351 | 0.020 |
Why?
|
Movement Disorders | 1 | 2012 | 459 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6377 | 0.020 |
Why?
|
Phenotype | 2 | 2021 | 16591 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1792 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2426 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2001 | 411 | 0.020 |
Why?
|
Patient Readmission | 1 | 2021 | 3270 | 0.020 |
Why?
|
Device Removal | 1 | 2012 | 630 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8465 | 0.020 |
Why?
|
Video Recording | 1 | 2012 | 966 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2017 | 1940 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2012 | 781 | 0.020 |
Why?
|
Pregnancy | 1 | 2007 | 29874 | 0.020 |
Why?
|
Laryngoscopy | 1 | 2001 | 706 | 0.020 |
Why?
|
Computer Systems | 1 | 2007 | 470 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5247 | 0.020 |
Why?
|
Antibodies, Antinuclear | 1 | 2006 | 343 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1664 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3743 | 0.010 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2012 | 992 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7827 | 0.010 |
Why?
|
Dexamethasone | 1 | 2001 | 1948 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2979 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8631 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9610 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5428 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6228 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3683 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1336 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4303 | 0.010 |
Why?
|
Information Dissemination | 1 | 2010 | 1126 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2001 | 1809 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7045 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14605 | 0.010 |
Why?
|
Age of Onset | 1 | 2006 | 3305 | 0.010 |
Why?
|
Migraine Disorders | 1 | 2012 | 1701 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8529 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 9000 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5294 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12463 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3290 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13506 | 0.010 |
Why?
|